These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6294275)

  • 1. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N; Kamata Y; Simpson LL
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing and phylogenetic analysis of neurotoxin gene from an environmental isolate of Clostridium sp.: comparison with other clostridial neurotoxins.
    Dixit A; Alam SI; Singh L
    Arch Toxicol; 2006 Jul; 80(7):399-404. PubMed ID: 16474961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL; Coffield JA; Bakry N
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
    Simpson LL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397
    [No Abstract]   [Full Text] [Related]  

  • 9. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1983 Jun; 225(3):546-52. PubMed ID: 6864519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.
    Dolly JO; Ashton AC; McInnes C; Wadsworth JD; Poulain B; Tauc L; Shone CC; Melling J
    J Physiol (Paris); 1990; 84(3):237-46. PubMed ID: 1963641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.
    Simpson LL
    J Pharmacol Exp Ther; 1980 Jan; 212(1):16-21. PubMed ID: 6243359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibodies as probes for the structure and biological activity of botulinum neurotoxin.
    Simpson LL; Kamata Y; Kozaki S
    J Pharmacol Exp Ther; 1990 Oct; 255(1):227-32. PubMed ID: 2213557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
    Sellin LC; Kauffman JA; Dasgupta BR
    Med Biol; 1983 Apr; 61(2):120-5. PubMed ID: 6308364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum neurotoxin].
    Poulain B
    Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease activity of botulinum neurotoxin type E and its light chain: cleavage of actin.
    DasGupta BR; Tepp W
    Biochem Biophys Res Commun; 1993 Jan; 190(2):470-4. PubMed ID: 8427588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxins: mechanism of action.
    Tighe AP; Schiavo G
    Toxicon; 2013 Jun; 67():87-93. PubMed ID: 23201505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S; Bartoszcze M; Gryko R
    Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.